From: Treatment related morbidity in differentiated thyroid cancer–a survey of clinicians
Complication (number of responders) | NA/Not involved | Don’t know | No agreed arrangements | Informal arrangements | Formal protocol |
---|---|---|---|---|---|
Temporary hypocalcaemia (118) | 1 (0.8%) | 1 (0.8) | 7(5.9%) | 32 (21.7%) | 77 (65.3%) |
Long term hypocalcaemia (117) | 2 (1.7%) | 0 (0.0%) | 13 (11.1%) | 51 (43.6%) | 51 (43.6%) |
Significant voice change (118) | 2 (1.7%) | 2 (1.7%) | 20 (16.9%) | 61 (51.7%) | 33 (28.0%) |
Symptoms/poor quality of life from TSH suppression (118) | 14 (11.9%) | 5 (4.2%) | 43 (36.4%) | 53 (44.9%) | 3 (2.5%) |
Bone/CVS complications from TSH suppression (118) | 17 (14.4%) | 8 (6.8%) | 47 (39.8%) | 42 (35.6%) | 4(3.4%) |